Western Wealth Management LLC lessened its position in Aflac Incorporated (NYSE:AFL – Free Report) by 82.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,093 shares of the financial services provider’s stock after selling 9,969 shares during the quarter. Western Wealth Management LLC’s holdings in Aflac were worth $234,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Aflac during the second quarter worth about $4,093,787,000. Legal & General Group Plc bought a new position in shares of Aflac during the 2nd quarter valued at about $404,639,000. Bank of New York Mellon Corp bought a new position in shares of Aflac during the 2nd quarter valued at about $298,418,000. Bank of America Corp DE purchased a new position in shares of Aflac during the 2nd quarter valued at about $244,516,000. Finally, Deutsche Bank AG bought a new stake in Aflac in the 2nd quarter worth approximately $222,375,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on AFL. UBS Group reaffirmed a “neutral” rating and issued a $125.00 target price (up from $124.00) on shares of Aflac in a research note on Tuesday, October 6th. JPMorgan Chase & Co. lifted their target price on shares of Aflac from $116.00 to $119.00 and gave the stock a “neutral” rating in a research report on Thursday, October 15th. Bank of America decreased their target price on Aflac from $137.00 to $133.00 and set a “buy” rating for the company in a report on Monday, October 12th. Wall Street Zen raised shares of Aflac from a “sell” rating to a “hold” rating in a research report on Saturday, November 7th. Finally, Barclays reaffirmed an “underweight” rating and set a $101.00 target price (up from $99.00) on shares of Aflac in a research note on Wednesday, October 7th. Four analysts have rated the stock with a Buy rating, eight have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $118.73.
View Our Latest Stock Analysis on Aflac
Top Aflac Stories
Here are a few of the latest stories about AFL:
- Positive Sentiment: Aflac raised its quarterly dividend to $0.64 per share from $0.61, an increase of about 5%. The new annualized payout is $2.56 per share, with a reported yield near 2.1% and payout ratio around 36%, supporting the stock’s income appeal. Aflac Inc's Dividend Analysis
- Neutral Sentiment: Major shareholder Post Holdings Co. Ltd. Japan reported several sales, including 15,000 shares on Nov. 18. The latest sale reduced its position by only about 0.03%, and the transactions were made under a pre-arranged Rule 10b5-1 plan. The repeated sales could attract attention, but their small size relative to its remaining stake limits their significance. Aflac insider trading information
- Negative Sentiment: Mizuho raised its price target to $117 from $112 but kept its Underperform rating. The target remains below the share price cited in recent trading data, reinforcing a cautious view of further upside. Mizuho raises Aflac target but retains Underperform rating
Insiders Place Their Bets
In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 113,611 shares of the business’s stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $118.53, for a total value of $13,466,311.83. Following the sale, the insider directly owned 50,134,329 shares of the company’s stock, valued at approximately $5,942,422,016.37. The trade was a 0.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 716,692 shares of company stock worth $84,434,467. 0.80% of the stock is owned by company insiders.
Aflac Trading Down 0.4%
NYSE:AFL opened at $124.32 on Friday. The firm has a market capitalization of $61.49 billion, a P/E ratio of 17.08, a PEG ratio of 1.78 and a beta of 0.55. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.11 and a quick ratio of 0.11. Aflac Incorporated has a one year low of $105.76 and a one year high of $131.18. The company’s 50-day simple moving average is $119.53 and its 200 day simple moving average is $117.04.
Aflac (NYSE:AFL – Get Free Report) last announced its earnings results on Wednesday, November 4th. The financial services provider reported $2.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.63. Aflac had a net margin of 21.24% and a return on equity of 12.82%. The business had revenue of $4.30 billion during the quarter, compared to the consensus estimate of $4.12 billion. During the same quarter last year, the firm earned $2.49 earnings per share. The business’s revenue for the quarter was down 31.0% on a year-over-year basis. As a group, analysts forecast that Aflac Incorporated will post 7.37 EPS for the current fiscal year.
Aflac Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 1st. Investors of record on Wednesday, February 17th will be given a dividend of $0.64 per share. This is a boost from Aflac’s previous quarterly dividend of $0.61. The ex-dividend date of this dividend is Wednesday, February 17th. This represents a $2.56 dividend on an annualized basis and a yield of 2.1%. Aflac’s dividend payout ratio is 35.57%.
Aflac Profile
Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.
Recommended Stories
- Five stocks we like better than Aflac
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
